KIK- MBIO
Not to say is has to go up more, as it already went up around 30% in a couple days. However with the Grant from the cancer institute in Ca for a phase 1 study with a new drug candidate, and having the rights from St Jude cancer institute for literally the cure for the boy in bubble disease, I think this latest grant news can take the stock to the $5 area soon. Either way, I doubt we see the stock go back down below $3.50 from here. So at $3.73, a $5 target suggests 34% upside.